TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank33
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-1256.81%
Near historical average
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-1369.30%
Historical baseline
PeriodValueYoY Change
TTM-1256.81%+72.2%
2024-4527.66%-968.2%
2023-423.86%+13.4%
2022-489.26%-2.0%
2021-479.49%+80.1%
2020-2408.02%-
20190.00%-